This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its chiral structure, particularly the (3R,4S) configuration, makes it valuable for the development of enantioselective drugs, especially those targeting the central nervous system. It is often employed in the production of inhibitors for enzymes like DPP-4, which are crucial in the treatment of type 2 diabetes. Additionally, its pyrrolidine core and amino functionality allow it to serve as a building block for creating compounds with potential antiviral, antibacterial, or anti-inflammatory properties. Its tert-butyl ester group enhances stability, making it suitable for use in complex synthetic pathways.